CEFACLOR RAN

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

cefaclor monohydrate, Quantity: 393.36 mg (Equivalent: cefaclor, Qty 375 mg)

제공처:

Medis Pharma Pty Ltd

INN (국제 이름):

cefaclor monohydrate

약제 형태:

Tablet, modified release

구성:

Excipient Ingredients: hypromellose; colloidal anhydrous silica; hyprolose; lactose monohydrate; purified talc; magnesium stearate; titanium dioxide; macrogol 400; indigo carmine aluminium lake; propylene glycol; purified water; isopropyl alcohol; iron oxide black

관리 경로:

Oral

패키지 단위:

10 tablets

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

For the treatment of the following infections caused by susceptible organisms, in adults and children 12 years and older: Lower respiratory infections, including community acquired pneumonia of mild to moderate severity (excluding atypical pneumonia), acute bronchitis and exacerbation of chronic bronchitis. Upper respiratory infections, including pharyngitis, tonsillitis and acute bacterial sinusitis. Symptomatic lower urinary tract infections, including cystitis. Skin and skin structure infections.

제품 요약:

Visual Identification: Capsule shaped, biconvex, unscored, blue film-coated tablet, imprinted with "Cefaclor CD 375mg" in black.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 18 Months; Container Temperature: Store below 25 degrees Celsius

승인 상태:

Licence status A

승인 날짜:

2011-08-09